Hypertrophic Obstructive Cardiomyopathy Research 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Therapeutic Strategy for Patients with Concomitant Pulmonary Artery Hypertension and Hypertrophic Obstructive Cardiomyopathy: A Rare Case Report
Medicina (Kaunas). 2023 Feb 18;59(2):401. doi: 10.3390/medicina59020401.ABSTRACTCombined cases of hypertrophic obstructive cardiomyopathy (HOCM) and pulmonary arterial hypertension (PAH) are rare and have a management dilemma. Although preload is crucial in the management of HOCM, anti-PAH agents dramatically change the preload, leading to improving or worsening heart failure in patients with HOCM. We had a 74-year-old woman with Sjogren-syndrome-associated PAH. Her heart failure worsened following the initiation of anti-PAH agents due to an incremental preload on the left ventricle, whereas HOCM clinically developed follo...
Source: Medicina (Kaunas) - February 25, 2023 Category: Universities & Medical Training Authors: Toshihide Izumida Teruhiko Imamura Shuhei Tanaka Shuji Joho Koichiro Kinugawa Source Type: research
Therapeutic Strategy for Patients with Concomitant Pulmonary Artery Hypertension and Hypertrophic Obstructive Cardiomyopathy: A Rare Case Report
Medicina (Kaunas). 2023 Feb 18;59(2):401. doi: 10.3390/medicina59020401.ABSTRACTCombined cases of hypertrophic obstructive cardiomyopathy (HOCM) and pulmonary arterial hypertension (PAH) are rare and have a management dilemma. Although preload is crucial in the management of HOCM, anti-PAH agents dramatically change the preload, leading to improving or worsening heart failure in patients with HOCM. We had a 74-year-old woman with Sjogren-syndrome-associated PAH. Her heart failure worsened following the initiation of anti-PAH agents due to an incremental preload on the left ventricle, whereas HOCM clinically developed follo...
Source: Medicina (Kaunas) - February 25, 2023 Category: Universities & Medical Training Authors: Toshihide Izumida Teruhiko Imamura Shuhei Tanaka Shuji Joho Koichiro Kinugawa Source Type: research
Therapeutic Strategy for Patients with Concomitant Pulmonary Artery Hypertension and Hypertrophic Obstructive Cardiomyopathy: A Rare Case Report
Medicina (Kaunas). 2023 Feb 18;59(2):401. doi: 10.3390/medicina59020401.ABSTRACTCombined cases of hypertrophic obstructive cardiomyopathy (HOCM) and pulmonary arterial hypertension (PAH) are rare and have a management dilemma. Although preload is crucial in the management of HOCM, anti-PAH agents dramatically change the preload, leading to improving or worsening heart failure in patients with HOCM. We had a 74-year-old woman with Sjogren-syndrome-associated PAH. Her heart failure worsened following the initiation of anti-PAH agents due to an incremental preload on the left ventricle, whereas HOCM clinically developed follo...
Source: Medicina (Kaunas) - February 25, 2023 Category: Universities & Medical Training Authors: Toshihide Izumida Teruhiko Imamura Shuhei Tanaka Shuji Joho Koichiro Kinugawa Source Type: research
Therapeutic Strategy for Patients with Concomitant Pulmonary Artery Hypertension and Hypertrophic Obstructive Cardiomyopathy: A Rare Case Report
Medicina (Kaunas). 2023 Feb 18;59(2):401. doi: 10.3390/medicina59020401.ABSTRACTCombined cases of hypertrophic obstructive cardiomyopathy (HOCM) and pulmonary arterial hypertension (PAH) are rare and have a management dilemma. Although preload is crucial in the management of HOCM, anti-PAH agents dramatically change the preload, leading to improving or worsening heart failure in patients with HOCM. We had a 74-year-old woman with Sjogren-syndrome-associated PAH. Her heart failure worsened following the initiation of anti-PAH agents due to an incremental preload on the left ventricle, whereas HOCM clinically developed follo...
Source: Medicina (Kaunas) - February 25, 2023 Category: Universities & Medical Training Authors: Toshihide Izumida Teruhiko Imamura Shuhei Tanaka Shuji Joho Koichiro Kinugawa Source Type: research
Therapeutic Strategy for Patients with Concomitant Pulmonary Artery Hypertension and Hypertrophic Obstructive Cardiomyopathy: A Rare Case Report
Medicina (Kaunas). 2023 Feb 18;59(2):401. doi: 10.3390/medicina59020401.ABSTRACTCombined cases of hypertrophic obstructive cardiomyopathy (HOCM) and pulmonary arterial hypertension (PAH) are rare and have a management dilemma. Although preload is crucial in the management of HOCM, anti-PAH agents dramatically change the preload, leading to improving or worsening heart failure in patients with HOCM. We had a 74-year-old woman with Sjogren-syndrome-associated PAH. Her heart failure worsened following the initiation of anti-PAH agents due to an incremental preload on the left ventricle, whereas HOCM clinically developed follo...
Source: Medicina (Kaunas) - February 25, 2023 Category: Universities & Medical Training Authors: Toshihide Izumida Teruhiko Imamura Shuhei Tanaka Shuji Joho Koichiro Kinugawa Source Type: research
Therapeutic Strategy for Patients with Concomitant Pulmonary Artery Hypertension and Hypertrophic Obstructive Cardiomyopathy: A Rare Case Report
Medicina (Kaunas). 2023 Feb 18;59(2):401. doi: 10.3390/medicina59020401.ABSTRACTCombined cases of hypertrophic obstructive cardiomyopathy (HOCM) and pulmonary arterial hypertension (PAH) are rare and have a management dilemma. Although preload is crucial in the management of HOCM, anti-PAH agents dramatically change the preload, leading to improving or worsening heart failure in patients with HOCM. We had a 74-year-old woman with Sjogren-syndrome-associated PAH. Her heart failure worsened following the initiation of anti-PAH agents due to an incremental preload on the left ventricle, whereas HOCM clinically developed follo...
Source: Medicina (Kaunas) - February 25, 2023 Category: Universities & Medical Training Authors: Toshihide Izumida Teruhiko Imamura Shuhei Tanaka Shuji Joho Koichiro Kinugawa Source Type: research
Therapeutic Strategy for Patients with Concomitant Pulmonary Artery Hypertension and Hypertrophic Obstructive Cardiomyopathy: A Rare Case Report
Medicina (Kaunas). 2023 Feb 18;59(2):401. doi: 10.3390/medicina59020401.ABSTRACTCombined cases of hypertrophic obstructive cardiomyopathy (HOCM) and pulmonary arterial hypertension (PAH) are rare and have a management dilemma. Although preload is crucial in the management of HOCM, anti-PAH agents dramatically change the preload, leading to improving or worsening heart failure in patients with HOCM. We had a 74-year-old woman with Sjogren-syndrome-associated PAH. Her heart failure worsened following the initiation of anti-PAH agents due to an incremental preload on the left ventricle, whereas HOCM clinically developed follo...
Source: Medicina (Kaunas) - February 25, 2023 Category: Universities & Medical Training Authors: Toshihide Izumida Teruhiko Imamura Shuhei Tanaka Shuji Joho Koichiro Kinugawa Source Type: research
Therapeutic Strategy for Patients with Concomitant Pulmonary Artery Hypertension and Hypertrophic Obstructive Cardiomyopathy: A Rare Case Report
Medicina (Kaunas). 2023 Feb 18;59(2):401. doi: 10.3390/medicina59020401.ABSTRACTCombined cases of hypertrophic obstructive cardiomyopathy (HOCM) and pulmonary arterial hypertension (PAH) are rare and have a management dilemma. Although preload is crucial in the management of HOCM, anti-PAH agents dramatically change the preload, leading to improving or worsening heart failure in patients with HOCM. We had a 74-year-old woman with Sjogren-syndrome-associated PAH. Her heart failure worsened following the initiation of anti-PAH agents due to an incremental preload on the left ventricle, whereas HOCM clinically developed follo...
Source: Medicina (Kaunas) - February 25, 2023 Category: Universities & Medical Training Authors: Toshihide Izumida Teruhiko Imamura Shuhei Tanaka Shuji Joho Koichiro Kinugawa Source Type: research
Therapeutic Strategy for Patients with Concomitant Pulmonary Artery Hypertension and Hypertrophic Obstructive Cardiomyopathy: A Rare Case Report
Medicina (Kaunas). 2023 Feb 18;59(2):401. doi: 10.3390/medicina59020401.ABSTRACTCombined cases of hypertrophic obstructive cardiomyopathy (HOCM) and pulmonary arterial hypertension (PAH) are rare and have a management dilemma. Although preload is crucial in the management of HOCM, anti-PAH agents dramatically change the preload, leading to improving or worsening heart failure in patients with HOCM. We had a 74-year-old woman with Sjogren-syndrome-associated PAH. Her heart failure worsened following the initiation of anti-PAH agents due to an incremental preload on the left ventricle, whereas HOCM clinically developed follo...
Source: Medicina (Kaunas) - February 25, 2023 Category: Universities & Medical Training Authors: Toshihide Izumida Teruhiko Imamura Shuhei Tanaka Shuji Joho Koichiro Kinugawa Source Type: research
Therapeutic Strategy for Patients with Concomitant Pulmonary Artery Hypertension and Hypertrophic Obstructive Cardiomyopathy: A Rare Case Report
Medicina (Kaunas). 2023 Feb 18;59(2):401. doi: 10.3390/medicina59020401.ABSTRACTCombined cases of hypertrophic obstructive cardiomyopathy (HOCM) and pulmonary arterial hypertension (PAH) are rare and have a management dilemma. Although preload is crucial in the management of HOCM, anti-PAH agents dramatically change the preload, leading to improving or worsening heart failure in patients with HOCM. We had a 74-year-old woman with Sjogren-syndrome-associated PAH. Her heart failure worsened following the initiation of anti-PAH agents due to an incremental preload on the left ventricle, whereas HOCM clinically developed follo...
Source: Medicina (Kaunas) - February 25, 2023 Category: Universities & Medical Training Authors: Toshihide Izumida Teruhiko Imamura Shuhei Tanaka Shuji Joho Koichiro Kinugawa Source Type: research
Therapeutic Strategy for Patients with Concomitant Pulmonary Artery Hypertension and Hypertrophic Obstructive Cardiomyopathy: A Rare Case Report
Medicina (Kaunas). 2023 Feb 18;59(2):401. doi: 10.3390/medicina59020401.ABSTRACTCombined cases of hypertrophic obstructive cardiomyopathy (HOCM) and pulmonary arterial hypertension (PAH) are rare and have a management dilemma. Although preload is crucial in the management of HOCM, anti-PAH agents dramatically change the preload, leading to improving or worsening heart failure in patients with HOCM. We had a 74-year-old woman with Sjogren-syndrome-associated PAH. Her heart failure worsened following the initiation of anti-PAH agents due to an incremental preload on the left ventricle, whereas HOCM clinically developed follo...
Source: Medicina (Kaunas) - February 25, 2023 Category: Universities & Medical Training Authors: Toshihide Izumida Teruhiko Imamura Shuhei Tanaka Shuji Joho Koichiro Kinugawa Source Type: research
Therapeutic Strategy for Patients with Concomitant Pulmonary Artery Hypertension and Hypertrophic Obstructive Cardiomyopathy: A Rare Case Report
Medicina (Kaunas). 2023 Feb 18;59(2):401. doi: 10.3390/medicina59020401.ABSTRACTCombined cases of hypertrophic obstructive cardiomyopathy (HOCM) and pulmonary arterial hypertension (PAH) are rare and have a management dilemma. Although preload is crucial in the management of HOCM, anti-PAH agents dramatically change the preload, leading to improving or worsening heart failure in patients with HOCM. We had a 74-year-old woman with Sjogren-syndrome-associated PAH. Her heart failure worsened following the initiation of anti-PAH agents due to an incremental preload on the left ventricle, whereas HOCM clinically developed follo...
Source: Medicina (Kaunas) - February 25, 2023 Category: Universities & Medical Training Authors: Toshihide Izumida Teruhiko Imamura Shuhei Tanaka Shuji Joho Koichiro Kinugawa Source Type: research
Therapeutic Strategy for Patients with Concomitant Pulmonary Artery Hypertension and Hypertrophic Obstructive Cardiomyopathy: A Rare Case Report
Medicina (Kaunas). 2023 Feb 18;59(2):401. doi: 10.3390/medicina59020401.ABSTRACTCombined cases of hypertrophic obstructive cardiomyopathy (HOCM) and pulmonary arterial hypertension (PAH) are rare and have a management dilemma. Although preload is crucial in the management of HOCM, anti-PAH agents dramatically change the preload, leading to improving or worsening heart failure in patients with HOCM. We had a 74-year-old woman with Sjogren-syndrome-associated PAH. Her heart failure worsened following the initiation of anti-PAH agents due to an incremental preload on the left ventricle, whereas HOCM clinically developed follo...
Source: Medicina (Kaunas) - February 25, 2023 Category: Universities & Medical Training Authors: Toshihide Izumida Teruhiko Imamura Shuhei Tanaka Shuji Joho Koichiro Kinugawa Source Type: research
Therapeutic Strategy for Patients with Concomitant Pulmonary Artery Hypertension and Hypertrophic Obstructive Cardiomyopathy: A Rare Case Report
Medicina (Kaunas). 2023 Feb 18;59(2):401. doi: 10.3390/medicina59020401.ABSTRACTCombined cases of hypertrophic obstructive cardiomyopathy (HOCM) and pulmonary arterial hypertension (PAH) are rare and have a management dilemma. Although preload is crucial in the management of HOCM, anti-PAH agents dramatically change the preload, leading to improving or worsening heart failure in patients with HOCM. We had a 74-year-old woman with Sjogren-syndrome-associated PAH. Her heart failure worsened following the initiation of anti-PAH agents due to an incremental preload on the left ventricle, whereas HOCM clinically developed follo...
Source: Medicina (Kaunas) - February 25, 2023 Category: Universities & Medical Training Authors: Toshihide Izumida Teruhiko Imamura Shuhei Tanaka Shuji Joho Koichiro Kinugawa Source Type: research
Therapeutic Strategy for Patients with Concomitant Pulmonary Artery Hypertension and Hypertrophic Obstructive Cardiomyopathy: A Rare Case Report
Medicina (Kaunas). 2023 Feb 18;59(2):401. doi: 10.3390/medicina59020401.ABSTRACTCombined cases of hypertrophic obstructive cardiomyopathy (HOCM) and pulmonary arterial hypertension (PAH) are rare and have a management dilemma. Although preload is crucial in the management of HOCM, anti-PAH agents dramatically change the preload, leading to improving or worsening heart failure in patients with HOCM. We had a 74-year-old woman with Sjogren-syndrome-associated PAH. Her heart failure worsened following the initiation of anti-PAH agents due to an incremental preload on the left ventricle, whereas HOCM clinically developed follo...
Source: Medicina (Kaunas) - February 25, 2023 Category: Universities & Medical Training Authors: Toshihide Izumida Teruhiko Imamura Shuhei Tanaka Shuji Joho Koichiro Kinugawa Source Type: research
